$54.99
Research Studies:
Available on backorder
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Livagen 20mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
Livagen 20mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 107667-60-7 |
|---|---|
| Molecular Formula | C16H26N4O7 |
| Molecular Weight | 402.40 g/mol |
| Purity | ≥99% |
| Sequence | Lys-Glu-Asp-Ala |
| Synthesis Method | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Water/Sterile Diluent |
| Stability & Storage | Up to 24 months at -20°C. Avoid repeated freeze-thaw cycles. |
| Applications | Gene expression research, anti-aging studies, cellular regeneration |
| Appearance | White to off-white powder |
| Regulatory/Compliance | Not for human consumption. For research use only. |
| Safety Information | MSDS available upon request |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy Livagen online should evaluate Livagen as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, Livagen purity documentation, batch-specific COAs, lot traceability, product labeling, storage information, and supplier evaluation. This guide explains how to evaluate Livagen 20mg for controlled research procurement through Pure Lab Peptides while keeping all buying intent limited to laboratory research-use-only sourcing.
Researchers can buy Livagen online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase buy Livagen online is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the relevant audience is qualified researchers, laboratory buyers, research institutions, and technical procurement teams evaluating a Livagen research material for controlled laboratory workflows.
Research-use-only sourcing is a documentation exercise. A buyer should be able to identify the compound, review the batch-specific COA, match the lot number across the label and documentation, confirm the listed product form, and determine whether the supplier avoids therapeutic, diagnostic, or personal-use positioning. FDA RUO guidance and federal labeling rules are useful reference points because they distinguish research-use labeling from clinical diagnostic positioning in regulated IVD contexts, even though procurement review for research peptides also requires compound-specific documentation and supplier transparency. [1] [2]
For Livagen research-use-only procurement, the safest commercial framing is “buy Livagen online for laboratory research.” That phrase keeps the evaluation focused on RUO labeling, Livagen COA review, Livagen identity testing, supplier documentation, product form, and lot traceability rather than consumer outcomes or product-use claims.
Livagen is commonly discussed as a short peptide or peptide bioregulator in research literature. Public chemical database indexing identifies the Livagen-related structure as H-Lys-Glu-Asp-Ala-OH, with the molecular formula C18H31N5O9 and PubChem CID 87919683. [3] In peptide terminology, peptides are amide-linked amino acid chains, and NIH educational material describes a peptide as a short chain of amino acids connected by peptide bonds. [4] [5]
The sequence-style description of Livagen is consistent with a tetrapeptide identity review: lysine, glutamic acid, aspartic acid, and alanine are represented by standard amino acid nomenclature and symbols used in peptide chemistry. [6] For procurement purposes, this means Livagen supplier documentation should allow researchers to compare the product name, peptide identity, sequence-style notation, molecular information, analytical method, and batch-specific COA fields.
Published research has examined Livagen or the KEDA tetrapeptide in several short-peptide research contexts, including chromatin-related laboratory studies, serum enzyme research, organotypic culture models, and broader peptide-regulation reviews. [7] [8] [9] [10] These papers are useful for research context only. They do not convert Livagen into a product for personal, therapeutic, diagnostic, veterinary, or consumer use.
Additional short-peptide literature has discussed lymphocyte chromatin, heterochromatin models, chromosome-fragility models, tetrapeptide KEDA, gene-expression review topics, and ultrashort peptide transport concepts. [11] [12] [13] [14] [15] [16] Because terms such as chromatin and epigenetic regulation can be used differently across research fields, procurement teams should separate literature context from product claims and rely on analytical documentation for material identity. [17]
Researchers search “buy Livagen online” when they need to compare RUO product availability, supplier documentation, and quality signals before selecting a laboratory source. The search does not need to imply personal-use interest. A technical procurement team may use the phrase to find a Livagen research material with clear RUO labeling, a batch-specific COA, purity data, identity documentation, and documented product form.
When a laboratory buyer searches to buy Livagen, the main review points should be documentation quality rather than promotional claims. Useful procurement signals include a consistent product name, an available Livagen COA, stated purity, analytical testing references, lot-level traceability, clear storage information, and Livagen supplier documentation that avoids dosing, therapeutic, diagnostic, or human-use language.
Product form also matters for laboratory planning. Pure Lab Peptides presents Livagen 20mg as lyophilized powder with a batch-specific COA available, a stated purity claim of ≥99%, and research-use-only positioning. Researchers should review the product page and batch-specific documentation before recording the material in laboratory procurement files.
Researchers searching to buy Livagen online for laboratory research should evaluate documentation before supplier selection. Analytical-method guidance for procedure validation, chromatography, and laboratory competence helps frame why method transparency and documentation consistency matter in research procurement review. [18] [19] [20]
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the available batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data where available | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
For peptide research materials, mass spectrometry and LC-MS methods are widely used in characterization workflows because they can support molecular-identity and impurity review when properly documented. [21] [22] [23]
A batch-specific COA should help researchers connect a specific lot of Livagen research material to the analytical documentation supplied for that lot. Relevant fields may include compound name, lot number, test date, stated purity percentage, testing method, identity confirmation, molecular weight where listed, sequence-style information where listed, chromatogram or mass data where available, product form, and storage documentation.
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. This is especially important for short peptides, where sequence confirmation, mass information, chromatography data, and batch matching may all contribute to a stronger documentation record. Analytical procedure validation guidance, chromatography references, peptide mass-spectrometry literature, and peptide handling recommendations all support the general principle that documentation should be method-aware and lot-specific. [18] [19] [21] [22] [23] [24]
For Livagen purity documentation, researchers should confirm that the COA and product page use consistent naming and lot information. For Livagen identity testing, researchers should review whether the documentation connects the material to peptide identity data rather than relying only on a generic product label.
Short peptide research literature should be discussed as scientific context, not as product-use guidance. Livagen appears in literature related to short peptide bioregulators, chromatin-related laboratory models, serum enzyme research, and organotypic culture contexts. [7] [8] [10] These publications can help researchers understand where the compound has appeared in scientific discussion, but they should not be treated as instructions for RUO material use.
Some Livagen-related publications involve human-derived samples or clinical-adjacent research settings outside the scope of RUO procurement. Published clinical literature should not be interpreted as use guidance for RUO materials. Procurement teams should cite such literature only as background context and should not convert it into claims about outcomes, effects, or appropriate use of a research-use-only material. [11] [12] [13]
Broader reviews and mechanistic discussions about peptide regulation, ultrashort peptide transport, and epigenetic terminology may be useful for interpreting the research landscape. [15] [16] [17] For procurement, however, the decisive questions remain practical and document-based: Does the product have RUO labeling, a batch-specific COA, identity support, purity data, lot traceability, product-form documentation, and transparent supplier language?
The Livagen evidence landscape should be separated into identity records, short-peptide literature, analytical testing methods, and supplier documentation. This separation prevents background literature from being presented as a product claim and keeps the article aligned with research-use-only procurement.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, or classification | Database / analytical | Supports identification, not product-use claims |
| Short peptide category context | Short peptide, tetrapeptide, chromatin-related, and model-specific research areas | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations | Laboratory documentation | Supports research workflow planning |
Database records and nomenclature references support basic identity review. [3] [6] Analytical references support review of chromatography, mass spectrometry, laboratory competence, and peptide handling documentation. [20] [24]
Because Livagen is a short peptide research material, claim boundaries are central to compliant procurement writing. The table below separates acceptable research phrasing from non-compliant product positioning.
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “Livagen is discussed in published research related to short peptide and chromatin-organization models.” | Describes literature context without making a product claim | “Livagen helps with a human outcome.” |
| “Researchers should review Livagen COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy Livagen for results.” |
| “Pure Lab Peptides supplies Livagen as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies Livagen for therapy.” |
| “The phrase buy Livagen online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy Livagen online for personal use.” |
| “Published literature should be treated as scientific context for qualified researchers.” | Separates background research from RUO product claims | “Published research proves a use outcome.” |
Pure Lab Peptides presents Livagen 20mg as a research-use-only material. The product is supplied as lyophilized powder, carries a stated ≥99% purity claim, and has a batch-specific COA available for review. Researchers should use the product page and batch-specific documentation to evaluate RUO labeling, product identity, purity information, storage and handling documentation, and lot-level traceability.
Review the Pure Lab Peptides Livagen 20mg research-use-only product page for RUO labeling, product details, purity information, and batch-specific documentation. Researchers comparing related research materials can also review the Pure Lab Peptides research peptide collection for supplier language, product documentation style, and RUO positioning.
Supplier transparency should be evaluated through documentation rather than promotional language. For Livagen, that means confirming the product form, checking the available batch-specific COA, matching the lot information, reviewing the purity claim, and ensuring the page does not position the material for human, animal, therapeutic, diagnostic, or consumer use.
Buy Livagen online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, lot traceability, and supplier transparency.
Published literature may identify research contexts in which Livagen or short peptide bioregulators have been examined, but that literature is not product-use guidance for RUO materials. Background papers should be cited as scientific context, not as claims about what a research material does.
A stated purity percentage is useful, but it does not independently confirm complete compound identity. Researchers should review Livagen purity documentation together with identity testing, method information, lot number, product name, and batch-specific COA consistency.
For procurement review, a COA is strongest when it connects to the specific lot being evaluated. A batch-specific Livagen COA helps researchers connect the material received with the documented purity, method, identity information, and lot-level recordkeeping.
RUO labeling does not support human-use, animal-use, diagnostic, therapeutic, or consumer positioning. For Livagen research-use-only procurement, RUO language should be read as a boundary: the material is intended for controlled laboratory research and documentation review.
Supplier statements cannot replace COA review, identity testing, method information, and lot traceability. Researchers should evaluate Livagen supplier documentation by comparing the product page, label, batch-specific COA, analytical method, and storage information.
Researchers can buy Livagen online for laboratory research by reviewing a supplier that presents the material with RUO labeling, batch-specific documentation, purity information, and lot traceability. Pure Lab Peptides provides a Livagen 20mg research-use-only product page for evaluating product details and available COA documentation.
Before buying Livagen online, researchers should check RUO labeling, the available batch-specific COA, purity data, identity information, lot-number consistency, product form, storage documentation, and supplier language. The evaluation should focus on research procurement records, not personal-use instructions or outcome claims.
A COA matters when buying Livagen because it helps connect a specific lot to documented purity, method information, and identity review. Researchers should keep the Livagen COA with procurement records and compare it against the label, product page, and internal inventory documentation.
Livagen discussed here is not intended for human or animal consumption. In this procurement guide, Livagen is addressed only as a research-use-only laboratory material for qualified researchers reviewing COA documentation, purity data, identity testing, storage information, and supplier transparency.
Research use only for Livagen means the material is positioned for controlled laboratory research procurement and documentation review. RUO positioning excludes personal-use, therapeutic, diagnostic, veterinary, and consumer-use framing. Researchers should rely on product labeling, COA documentation, and supplier transparency.
Published literature about Livagen should be interpreted as scientific context, not product-use guidance for an RUO material. Researchers may cite literature to understand compound identity, category context, or model-specific research areas, but procurement decisions should depend on RUO labeling, COA documentation, and analytical support.
Qualified researchers evaluating Livagen should review product labeling, COA status, identity documentation, storage information, purity data, and supplier transparency before selecting any research-use-only material. Review the Livagen 20mg product page for RUO labeling, purity information, and available batch-specific documentation.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.